Introduction
The monocarboxylate transporter 8 (MCT8) is the most specific thyroid hormone (TH) transmembrane transporter that is currently known. Mutations in MCT8 lead to a severe form of psychomotor retardation, the Allan-Herndon-Dudley syndrome [1] . Patients present with neurological symptoms including severe hypotonia, lack of speech and poor mental development. Specific endocrine abnormalities in circulating TH levels (low T 4 , high T 3 ) in the face of normal-to-elevated thyroid-stimulating hormone levels paved the way to the discovery of underlying mutations in MCT8 in these patients [2, 3] . Mouse models for Mct8 deficiency have been generated and replicate the endocrine phenotype seen in humans [4] [5] [6] . Low circulating T 4 and high circulating T 3 levels lead to the manifestation of local hypo-or hyperthyroidism in different organs and tissues depending on the presence of other TH transmembrane transporters. Tissues like liver [4, 5] , muscle [7] and kidney [8] are reportedly in a hyperthyroid state in Mct8 deficiency evaluated by deiodinase activities, while the brain shows signs of hypothyroidism measured by reduced uptake of T 3 into the brain and increased deiodinase 2 activity [4, 5] or mixed hypo-and hyperthyroid changes assessed by behavioral analysis [9] .
To date, it is unclear what causes the low circulating T 4 and high T 3 concentrations. Several explanations have been suggested. Mct8 -deficient mice demonstrate enhanced uptake and clearance of TH via the kidney possibly leading to a reduction of T 4 and T 3 in serum [8] . TH also accumulate in Mct8 -deficient thyroid glands and are secreted at a slower rate upon thyroid-stimulating hormone stimulation [10, 11] . However, these findings do not seem to account for the low T 4 and elevated T 3 serum levels since they originate from enhanced metabolism of TH and not from increased loss in the kidney or reduced secretion from the thyroid gland.
In 2011, Liao et al. [12] determined the consequences of combined Mct8 and Dio1 and/or Dio2 deficiency on the hypothalamus-pituitary-thyroid axis. They nicely demonstrated that the global deletion of Dio1 in Mct8 -deficient animals leads to a nearly complete normalization of circulating T 4 and T 3 , as well as thyroid-stimulating hormone levels. It was therefore concluded that increased conversion of T 4 into T 3 by Dio1 is responsible for the elevated circulating T 3 and reduced T 4 levels in Mct8 deficiency. To directly test this hypothesis, we made use of our previously described hepatocyte-specific selenoprotein-deficient mice (Alb-Cre ; Trsp fl/fl ) that are devoid of deiodinase activity in hepatocytes [13] . Our model revealed that deletion of Dio1 activity in livers of Mct8 -deficient mice has no major impact on circulating TH levels and is therefore not the underlying cause for the observed low T 4 and high T 3 serum levels in Mct8 deficiency.
Material and Methods

Animals
All animal experiments were approved by the local authorities in Berlin, Germany, and have been performed according to local regulations at the Charité-Universitätsmedizin Berlin (Germany). Alb-Cre ; Trsp fl/fl as well as Mct8 -deficient mice have been described before [9, 13] . The data presented in this paper were generated using only male mice with the genotypes wild type (wt), Mct8 -/y , Alb-Cre ; Trsp fl/fl and Alb-Cre ; Trsp fl/fl ;Mct8 -/y . Mating was set up in a way to obtain animals of all genotypes as littermates.
Type I Deiodinase Assay
Activities of the type I deiodinase (Dio1) were determined in triplicate in liver homogenates (40 μg protein/ml) based on an iodide-release protocol [14] with slight modifications. Liver homogenates were incubated at 37 ° C for 60 min with 20 m M 1,4-dithiothreitol as cosubstrate, 0.3 μ M nonradiolabeled rT 3 and 125 I-radiolabeled rT 3 (PerkinElmer, Hamburg, Germany; 0.82 μCi/pmol) in the absence or presence of 1 m M propylthiouracil (PTU). The reaction was stopped by adding cold 10% BSA, and 0.01 m M PTU and proteins were precipitated by adding 3 volumes of cold 10% trichloroacetic acid. Samples were centrifuged and the supernatant was eluted over a Dowex-50 WX-2 column. The 125 I in the eluate was counted using a gamma counter (1277 GammaMaster; LKB Wallac, Turku, Finland). The absence or presence of H 2 O or PTU in the reaction mixture differentiated between Dio1 activity and total deiodinase activity as the fraction of 125 I release blocked by PTU was assigned to Dio1.
TH Assay
Total T 4 and T 3 levels were measured by competitive radioimmunoassays from DRG Instruments (Marburg, Germany). Samples and calibrators for a standard curve were incubated with 125 I-T 4 or 125 I-T 3 as a tracer in antibody-coated tubes for 1 h. Bound radioactivity was determined in a gamma counter (1277 GammaMaster; LKB Wallac, Turku, Finland).
Results
Inactivation of Hepatocyte-Specific Deiodinase Activity in Mct8-Deficient Mice
At present, a mouse model for the conditional inactivation of the Dio1 gene is not available. We therefore took advantage of the fact that deiodinases are selenoenzymes, i.e. enzymes carrying the rare amino acid selenocysteine (Sec). Incorporation of Sec depends on tRNA (Sec) , which is encoded by the gene Trsp , of which a mouse model for the conditional inactivation is available. We have previously reported that hepatocyte-specific inactivation of selenoprotein translation abrogated hepatic deiodinase activity in Alb-Cre ; Trsp fl/fl mice [13] . Expression of all selenoproteins is quantitatively abolished in livers of AlbCre ; Trsp fl/fl mice [15] . Ablation of selenoprotein biosynthesis in hepatocytes does not lead to liver failure or other diseases [16, 17] . Hence, we crossed global Mct8 -deficient mice with our liver-specific deiodinase-deficient mice in order to test the hypothesis that hepatic deiodinase causes increased T 4 to T 3 conversion and subsequently low T 4 , high T 3 serum levels in Mct8 deficiency [9, 13] -/y mice had a slightly reduced bw at the age of 2-3 months ( fig. 1 a) . Heart weight did not differ between groups when normalized for bw, indicating no hypertrophic effect of TH on the heart in this age group ( fig. 1 b) . As expected, Mct8 -deficient mice ( Mct8 -/y ) have higher Dio1 activity in the liver than their littermate controls ( fig. 1 c) . Inactivation of deiodinases in control or Mct8 -deficient mice reduced Dio1 activity to levels close to the detection limit ( fig. 1 c) . Residual Dio1 activity most likely stems from the very low amount of Dio1 that is expressed outside of hepatocytes in the liver, possibly in Kupffer cells. 
Effect of Hepatic Dio1 Deficiency in Mct8-Deficient Mice on Circulating TH
Since combined global inactivation of Dio1 and Mct8 led to the normalization of circulating TH levels, we measured circulating levels of total T 4 and total T 3 to see the impact of hepatic Dio1 inactivation on TH metabolism in global Mct8 -deficient mice. Also in this combined mouse model, we can replicate the known endocrine phenotype of Mct8 deficiency with low T 4 
and high T 3 levels in Mct8
-/y as compared to littermate controls ( fig. 2 ) . Inactivation of hepatic deiodinase activity led to only marginally increased total T 4 serum levels in Mct8 -deficient mice. A slight increase in circulating T 4 levels upon hepatic Dio1 inactivation has been described before and may be related to reduced inactivation of T 4 [18] . Loss of Dio1 activity in Mct8 -deficient livers does also not lead to a normalization of circulating T 3 levels ( fig. 2 ) 
Discussion
High circulating T 3 concentrations in MCT8 -deficient patients are considered to be responsible for increased energy expenditure and muscle wasting. At the same time, feeding the patients adequately is challenging, given their impaired motor capabilities, and weight loss often occurs. Serum TH constellations with high T 3 and low T 4 concentrations in MCT8 -deficient patients are considered to be responsible for a variety of these peripheral phenotypes through hyperthyroid states in MCT8-independent tissues like skeletal muscle and liver. Lowering serum T 3 may thus represent a therapeutic goal, but this is difficult to achieve in the presence of abnormally low T 4 levels in the patients. Local conversion of T 4 to T 3 is the major source of cerebral T 3 . Therefore, treatments potentially lowering T 4 are at risk of further reducing cerebral TH uptake and T 3 availability. It is thus a pertinent question how these altered serum TH levels are caused.
Although a variety of data have been collected in mouse models of Mct8 deficiency, the mechanism for the 90 manifestation of these altered serum TH levels is still unclear. Loss of TH through the kidney was proposed [8] . How increased total T 3 could be maintained while T 4 is selectively lost is difficult to envision at present. Reduced secretion of TH from the thyroid gland itself has also been proposed [10, 11] . How the release of T 4 could be lowered while at the same time T 3 release would be increased from the thyroid gland is again not clear. Moreover, a patient with a mutation in MCT8 treated with levothyroxine after a complete thyroidectomy maintained the high T 3 , low T 4 levels in serum [6] . Increased conversion of T 4 to T 3 by deiodinases is thus a possible explanation. Combined deletion of Mct8 and Dio1 in mice resulted in a normalization of serum TH parameters and subsequent improvement of brain T 3 content [12] . In contrast, genetic inactivation of Dio2 in Mct8 -deficient mice did not improve TH serum concentrations and, on the contrary, increased changes in brain gene expression.
These data suggested that peripheral conversion of T 4 to T 3 via Dio1 may establish the high T 3 , low T 4 hormonal constellation in Mct8 deficiency. Since increased access of T 3 to the liver does not depend on Mct8 and further stimulates Dio1 expression, hepatic Dio1-mediated conversion of T 4 represented a plausible mechanism of establishing the abnormal TH levels outlined before. Nonetheless, our data presented here appear to refute this attractive hypothesis. -/y mice also displayed a minor increase in T 4 , while circulating T 3 levels were not normalized compared to Mct8 -deficient mice. Data are presented as means ± SEM. * p < 0.05; * * p < 0.01; * * * p < 0.001 (Mann-Whitney U test).
